Tesamorelin: the visceral-fat GHRH analog
An FDA-approved growth-hormone-releasing hormone analog studied specifically for reducing deep abdominal fat — not a general weight-loss drug.
An FDA-approved growth-hormone-releasing hormone analog studied specifically for reducing deep abdominal fat — not a general weight-loss drug.
A fragment of growth hormone studied for targeting fat breakdown — promising in theory, but with limited and mixed human evidence. Here’s the honest picture.
An FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management — one of the most rigorously studied peptides on this site.
A mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and cellular energy.
Honest, sourced peptide writing — plus the free Peptide Stacking Bible when you join.